Lenvatinib Impurity 27

Stability indicating UPLC method development and validation of lenvatinib
By Sai, Prasanna A.; Kumar, Meruva Sathish; Kumari, R. V. Valli; Marakatham, S.
From International Journal of Pharmacy and Biological Sciences (2019), 9(3), 605-614
 
Method validation studies and an inter-​laboratory cross validation study of lenvatinib assay in human plasma using LC-​MS​/MS
By Mano Yuji
From Practical laboratory medicine (2018), 12, e00103

Lenvatinib Impurity 27 is chemically (E)-4-((2-Chloro-4-hydroxyphenyl)diazenyl)benzenesulfonic acid. Lenvatinib Impurity 27 is supplied with detailed characterization data compliant with regulatory guideline. Lenvatinib Impurity 27 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lenvatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.